Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies

Journal of Molecular Medicine

Volumn 78, Issue 10, 2000, Pages 543-553

  Michele, Daniel E ^a   Metzger, Joseph M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Calcium; Hypertrophic cardiomyopathy; Muscle contraction; Nemaline myopathy; Tropomyosin

Indexed keywords

TROPOMYOSIN;

CALCIUM CELL LEVEL; CARDIOMYOPATHY; CLINICAL FEATURE; GENE MUTATION; GENE TRANSFER; HEART MUSCLE CELL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE FORCE; MUSCLE FUNCTION; MYOPATHY; NEMALINE MYOPATHY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SARCOMERE; SKELETAL MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; MYOCARDIAL CONTRACTION; MYOPATHIES, NEMALINE; TROPOMYOSIN;

EID: 0034514136     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000161     Document Type: Review

References (78)

1. Thin filament-mediated regulation of cardiac contraction
2. Regulation of contraction in striated muscle
3. The molecular basis for tropomyosin isoform diversity
4. Molecular diversity of myofibrillar proteins: Gene regulation and functional significance
5. Familial hypertrophic cardiomyopathy: A genetic model of cardiac hypertrophy
6. Familial hypertrophic cardiomyopathy: From mutations to functional defects
7. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort
8. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles
9. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
10. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
11. Novel missense mutation in alpha-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy
12. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene
13. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population
14. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations
15. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene
16. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2
17. Structure of cocrystals of tropomyosin and troponin
18. Tropomyosin coiled-coil interactions: Evidence for an unstaggered structure
19. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function
20. Human hTM alpha gene: Expression in muscle and nonmuscle tissue
21. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy
22. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy
23. A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy
24. Nemaline myopathy: Current concepts. The ENMC International Consortium and Nemaline Myopathy
25. Immunofluorescence microscopy of a myopathy, alpha-Actinin is a major constituent of nemaline rods
26. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy
27. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy
28. Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy
29. Clinical and genetic heterogeneity in autosomal recessive nemaline myopathy
30. Congenital nemaline myopathy with dilated cardiomyopathy: An autopsy study
31. Alpha-helical protein assembly motifs
32. Crystal structure of tropomyosin at 7 Angstroms resolution
33. The structure of the N-terminus of striated muscle alpha-tropomyosin in a chimeric peptide: Nuclear magnetic resonance structure and circular dichroism studies
34. The amino terminus of muscle tropomyosin is a major determinant for function
35. Non-polymerizable tropomyosin: Preparation, some properties and F-actin binding
36. Targeted ablation of the murine alpha-tropomyosin gene
37. Molecular and physiological effects of alpha-tropomyosin ablation in the mouse
38. Molecular and physiological effects of overexpressing striated muscle betatropomyosin in the adult murine heart
39. Molecular remodeling of cardiac contractile function
40. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart
41. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: An ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly
42. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes
43. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility
44. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins
45. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action
46. Adenovirus-mediated myofilament gene transfer into adult cardiac myocytes
47. Skeletal troponin C reduces contractile sensitivity to acidosis in cardiac myocytes from transgenic mice
48. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy
49. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy
50. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
51. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy
52. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy
53. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction
54. A mouse model of familial hypertrophic cardiomyopathy
55. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
56. 2+-activated tension in adenovirus infected adult cardiac myocytes
57. Slow skeletal troponin I gene transfer, expression, and myofilament incorporation enhances adult cardiac myocyte contractile function
58. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy
59. Tropomyosin modulates pH dependence of isometric tension
60. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function
61. Structure-function analysis of cytoskeletal/contractile proteins in avian myotubes
62. Investigation of a truncated cardiac troponin T that causes familial hypertrophic cardiomyopathy: Ca(2+) regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein
63. Thin filament protein dynamics in fully differentiated adult cardiac myocytes: Toward a model of sarcomere maintenance
64. A nemaline myopathy mutation in alpha-tropomyosin causes defective regulation of striated muscle force production
65. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes
66. Myoplasmic free calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle
67. Left ventricular diastolic function in hypertrophic cardiomyopathy
68. Variation in myoplasmic Ca2+ concentration during contraction and relaxation studied by the indicator fluo-3 in frog muscle fibres
69. Human immunodeficiency virus-associated myopathy: Analysis of 11 patients
70. Sarcomere dynamics and contraction-induced injury to maximally activated single muscle fibres from soleus muscles of rats
71. Experimental core-like lesions and nemaline rods: A correlative morphological and physiological study
72. The cellular and molecular response of cardiac myocytes to mechanical stress
73. Regulation of the interaction between actin and myosin subfragment 1: Evidence for three states of the thin filament
74. An atomic model of the unregulated thin filament obtained by X-ray fiber diffraction on oriented actin-tropomyosin gels
75. Tropomyosin control of thin filament activity revealed by electron microscopy and 3-D reconstruction
76. Myosin binding-induced cooperative activation of the thin filament in cardiac myocytes and skeletal muscle fibers
77. Will calcium sensitizers play a role in the treatment of heart failure?
78. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil